A novel blocking monoclonal antibody recognizing a distinct epitope of human CD40 molecule

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• CD40 is a crucial costimulatory molecule in immune responses, belonging to the tumor necrosis factor receptor superfamily.
• Understanding CD40's role is vital for immune system research and therapeutic development.

Purpose of the Study:

• To characterize a novel blocking mouse antihuman CD40 monoclonal antibody, mAb 3G3.
• To evaluate mAb 3G3's potential in inhibiting CD40-mediated cellular functions.
• To develop a diagnostic tool for immune disorders using mAb 3G3.

Main Methods:

• Specificity of mAb 3G3 was confirmed using flow cytometry and Western blot.
• Competition assays determined mAb 3G3 binds to a unique epitope on CD40.
• Functional assays included inhibition of Daudi cell aggregation and peripheral blood mononuclear cell proliferation.
• A soluble CD40 (sCD40) ELISA kit was developed using mAb 3G3 and an agonistic antibody.

Main Results:

• mAb 3G3 demonstrated high specificity and bound to a distinct epitope compared to other CD40 antibodies.
• The antibody effectively inhibited CD40-mediated homotypic aggregation of Daudi cells.
• mAb 3G3 significantly suppressed peripheral blood mononuclear cell proliferation in mixed lymphocyte reactions.
• Elevated sCD40 levels were detected in patients with hyperthyroidism, chronic nephritis, and rheumatoid arthritis.

Conclusions:

• mAb 3G3 is a potent blocking antibody with a unique epitope, offering a valuable tool for studying CD40.
• The developed sCD40 ELISA kit shows promise for diagnosing immune disorders.
• This research provides new insights into CD40's function and its potential as a biomarker.